申请人:AstraZeneca AB
公开号:US07902181B2
公开(公告)日:2011-03-08
The present invention provides compounds of formula (I)
in which n, y, X1, X2, A, B, R1, R2, R3, R4 and R5 are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
本发明提供了式(I)化合物,其中n,y,X1,X2,A,B,R1,R2,R3,R4和R5如规范中所定义,以及它们的制备方法,含有它们的制药组合物以及它们在治疗中的用途。